FDA Inspection 682973 — Lilly del Caribe, Inc.

Lilly del Caribe, Inc. — FEI 3004525072

The FDA completed an inspection of Lilly del Caribe, Inc. on September 15, 2010 in Carolina, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)